Miller Justin E, Srinivasan Yashes, Dharmaraj Nithin P, Liu Andrew, Nguyen Phillip L, Taylor Scott D, Yeates Todd O
UCLA Molecular Biology Institute, 611 Charles E. Young Drive East, Los Angeles, California 90095-1570, United States.
UCLA-DOE Institute for Genomics and Proteomics, 611 Charles E. Young Drive East, Los Angeles, California 90095-1570, United States.
J Am Chem Soc. 2022 Jul 20;144(28):12681-12689. doi: 10.1021/jacs.2c02165. Epub 2022 Jul 8.
Proteins that self-assemble into enclosed polyhedral cages, both naturally and by design, are garnering attention for their prospective utility in the fields of medicine and biotechnology. Notably, their potential for encapsulation and surface display are attractive for experiments that require protection and targeted delivery of cargo. The ability to control their opening or disassembly would greatly advance the development of protein nanocages into widespread molecular tools. Toward the development of protein cages that disassemble in a systematic manner and in response to biologically relevant stimuli, here we demonstrate a modular protein cage system that is opened by highly sequence-specific proteases, based on sequence insertions at strategically chosen loop positions in the protein cage subunits. We probed the generality of the approach in the context of protein cages built using the two prevailing methods of construction: genetic fusion between oligomeric components and (non-covalent) computational interface design between oligomeric components. Our results suggest that the former type of cage may be more amenable than the latter for endowing proteolytically controlled disassembly. We show that a successfully designed cage system, based on oligomeric fusion, is modular with regard to its triggering protease. One version of the cage is targeted by an asparagine protease implicated in cancer and Alzheimer's disease, whereas the second version is responsive to the blood-clotting protease, thrombin. The approach demonstrated here should guide future efforts to develop therapeutic vectors to treat disease states where protease induction or mis-regulation occurs.
无论是天然的还是通过设计自组装成封闭多面体笼状结构的蛋白质,因其在医学和生物技术领域的潜在应用价值而备受关注。值得注意的是,它们的封装和表面展示潜力对于需要保护和靶向递送货物的实验具有吸引力。控制其打开或拆解的能力将极大地推动蛋白质纳米笼发展成为广泛应用的分子工具。为了开发能够以系统方式并响应生物相关刺激而拆解的蛋白质笼,我们在此展示了一种模块化蛋白质笼系统,该系统基于在蛋白质笼亚基中策略性选择的环位置进行序列插入,可被高度序列特异性蛋白酶打开。我们在使用两种主要构建方法构建的蛋白质笼背景下探究了该方法的通用性:寡聚体成分之间的基因融合以及寡聚体成分之间的(非共价)计算界面设计。我们的结果表明,前一种类型的笼子可能比后一种更适合赋予蛋白水解控制的拆解能力。我们表明,基于寡聚体融合成功设计的笼系统在其触发蛋白酶方面具有模块化特点。一种版本的笼子被与癌症和阿尔茨海默病相关的天冬酰胺蛋白酶靶向,而第二种版本对凝血蛋白酶凝血酶有反应。此处展示的方法应指导未来开发治疗载体以治疗发生蛋白酶诱导或调节异常的疾病状态的努力。